STOCK TITAN

TVTX (NASDAQ: TVTX) insider files to sell 6,956 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

TVTX insider Jula Inrig has filed a Form 144 indicating an intent to sell 6,956 shares of common stock through Morgan Stanley Smith Barney on or about 02/03/2026 on the NASDAQ, with an aggregate market value of $223,429.38. The shares were acquired on 01/31/2026 via restricted stock unit vesting from the issuer as compensation.

Over the prior three months, Jula Inrig sold additional common shares in three transactions: 445 shares for $16,798.75, 2,031 shares for $81,605.58, and 15,000 shares for $630,004.50. The filing also notes a representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the TVTX Form 144 filing by Jula Inrig disclose?

The filing discloses a planned sale of 6,956 TVTX common shares. Jula Inrig intends to sell these shares through Morgan Stanley Smith Barney on or about February 3, 2026, on NASDAQ, with an aggregate market value reported as $223,429.38.

How were the 6,956 TVTX shares in the Form 144 acquired?

The 6,956 shares were acquired through restricted stock unit vesting. The acquisition occurred on January 31, 2026, as compensation from the issuer, according to the filing’s securities-to-be-sold table describing the nature and date of the acquisition transaction.

What prior TVTX share sales by Jula Inrig are reported in this Form 144?

The filing lists three TVTX common share sales in the past three months. These include 15,000 shares sold on December 24, 2025, 2,031 shares on January 5, 2026, and 445 shares on January 6, 2026, with stated gross proceeds for each transaction.

Which broker and exchange are involved in the planned TVTX share sale?

The planned sale will use Morgan Stanley Smith Barney and the NASDAQ exchange. The broker’s Alpharetta, Georgia address is listed, and NASDAQ is named as the securities exchange for the 6,956 common shares to be sold under Rule 144.

What representation does the seller make about TVTX information in this Form 144?

The seller represents not knowing undisclosed material adverse information about TVTX. By signing the notice, the person confirms they are unaware of material adverse information on current or prospective operations that has not been publicly disclosed.

How many TVTX common shares are reported as outstanding in the Form 144?

The filing reports 89,472,327 TVTX common shares outstanding. This figure appears in the securities information section alongside the planned sale of 6,956 shares, providing context on the issuer’s total common share count at the time referenced.
Travere Therapeutics Inc

NASDAQ:TVTX

TVTX Rankings

TVTX Latest News

TVTX Latest SEC Filings

TVTX Stock Data

2.96B
82.79M
0.75%
117.25%
13.55%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO